Cellcept and Copegus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Copegus (ribavirin). Common drug interactions include hypertension among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Copegus. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Copegus?

Copegus has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 15,115 Copegus users. Check the latest studies of Copegus.

On Jul, 12, 2026

72 people who take Cellcept and Copegus together, and have interactions are studied.

What are the common drug interactions of Cellcept and Copegus, by gender? *:

female:

Hypertension (high blood pressure)
Liver disorder (liver diseases)
Liver transplant
Pyrexia (fever)
Renal impairment (severely reduced kidney function)
Staphylococcal bacteraemia (a bacterial infection of blood)
Cardiac disorder
Gamma-glutamyltransferase increased
Hepatocellular injury (liver injury)
Lung disorder (lung disease)

male:

Confusional state
Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
Renal impairment (severely reduced kidney function)
Ammonia increased
Fatigue (feeling of tiredness)
Anaemia (lack of blood)
Ascites (accumulation of fluid in the abdominal cavity)
Diarrhoea
Haemoglobin decreased
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the common drug interactions of Cellcept and Copegus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Death
Drug level decreased
Immunosuppressant drug level decreased
Kidney transplant rejection
Meningitis fungal (fungal inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)

40-49:

Depression
Back pain
Diarrhoea
Fungal skin infection
Fatigue (feeling of tiredness)
Haemoglobin decreased
Rash
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Memory impairment
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

50-59:

Confusional state
Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
Aggression
Agitation (state of anxiety or nervous excitement)
Anaemia (lack of blood)
Blood creatinine increased
Renal impairment (severely reduced kidney function)
Respiratory failure (inadequate gas exchange by the respiratory system)
Dyspnoea (difficult or laboured respiration)
Ascites (accumulation of fluid in the abdominal cavity)

60+:

Liver transplant
Renal failure acute (rapid kidney dysfunction)
Dyspepsia (indigestion)
Fatigue (feeling of tiredness)
Hyperthermia (body temperature greatly above normal)
Malaise (a feeling of general discomfort or uneasiness)
Ocular icterus (presence of jaundice seen in the sclera of the eye)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
Postoperative renal failure

What are the existing conditions these people have? *

Pneumonia Fungal: 7 people, 9.72%
Pneumonia: 7 people, 9.72%
Anaemia (lack of blood): 7 people, 9.72%
High Blood Pressure: 6 people, 8.33%
Diabetes: 6 people, 8.33%
Transplant Rejection (a transplant material is not worked): 5 people, 6.94%
Pain: 5 people, 6.94%
Immunodeficiency Disorders: 5 people, 6.94%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Copegus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously